Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSII
601
DELISTED
Heidrick & Struggles
HSII
| $30.6M | 0.03% |
1,416,002
+141,602
| +11% | +$3.12M |
|
602
Micron Technology
MU
$1.07T
| $30.6M | 0.03% |
593,736
-55,800
| -9% | -$2.63M |
|
603
CBRE Group
CBRE
$44B
| $30.5M | 0.03% |
673,700
+435,800
| +183% | +$18.8M |
|
604
Emergent Biosolutions
EBS
$230M
| $30.4M | 0.03% |
384,624
-238,377
| -38% | -$17.8M |
|
605
International Paper
IP
$21.8B
| $30.4M | 0.03% |
911,750
+541,411
| +146% | +$17.2M |
|
606
American Eagle Outfitters
AEO
$2.73B
| $30.4M | 0.03% |
2,787,711
+139,377
| +5% | +$1.32M |
|
607
AtriCure
ATRC
$2.21B
| $30.3M | 0.03% |
673,475
+138,975
| +26% | +$6.05M |
|
608
Armstrong World Industries
AWI
$7.68B
| $30.2M | 0.03% |
386,800
-324,500
| -46% | -$24.6M |
|
609
Kite Realty
KRG
$5.31B
| $30.1M | 0.03% |
2,611,399
-615,799
| -19% | -$6.18M |
|
610
Southside Bancshares
SBSI
$984M
| $30.1M | 0.03% |
1,084,185
-4,361
| -0.4% | -$124K |
|
611
Cognizant
CTSH
$26.7B
| $30M | 0.03% |
528,565
-682,143
| -56% | -$36.6M |
|
612
Paycom
PAYC
$10.1B
| $30M | 0.03% |
96,950
-38,200
| -28% | -$10.2M |
|
|
AHRT
613
AH Realty Trust
AHRT
$506M
| $30M | 0.03% |
3,015,809
-838,600
| -22% | -$7.6M |
|
|
PRMW
614
DELISTED
Primo Water Corporation
PRMW
| $30M | 0.03% |
2,178,360
-323,083
| -13% | -$3.62M |
|
615
VF Corp
VFC
$5.79B
| $29.9M | 0.03% |
+491,200
| New | +$28.6M |
|
616
Waterstone Financial
WSBF
$385M
| $29.8M | 0.03% |
2,009,544
-57,400
| -3% | -$813K |
|
617
PennyMac Financial
PFSI
$4.13B
| $29.8M | 0.03% |
713,022
-259,927
| -27% | -$8.23M |
|
618
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $29.7M | 0.03% |
264,183
-19,500
| -7% | -$2.07M |
|
619
Materion
MTRN
$5.88B
| $29.6M | 0.03% |
481,411
-55,700
| -10% | -$2.82M |
|
620
ManpowerGroup
MAN
$2.75B
| $29.4M | 0.03% |
428,352
+415,700
| +3,286% | +$28.4M |
|
621
Capital One
COF
$137B
| $29.4M | 0.03% |
470,435
+63,336
| +16% | +$3.94M |
|
622
Revvity
RVTY
$13.1B
| $29.4M | 0.03% |
+300,100
| New | +$27.4M |
|
623
Teradata
TDC
$2.57B
| $29.4M | 0.03% |
1,415,219
-308,568
| -18% | -$6.71M |
|
624
Howmet Aerospace
HWM
$113B
| $29.3M | 0.03% |
1,850,400
+170,587
| +10% | +$2.24M |
|
625
argenx
ARGX
$53.6B
| $29.3M | 0.03% |
130,014
+78,641
| +153% | +$14M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.